ENDV
ENDONOVO THERAPEUTICS, INC.
Key Financials
Operating Income
$-3264340
↓ 46.6%
Gross Profit
$125365
↑ 115.7%
Net Income
$-18474835
↓ 495.0%
Revenue
$135355
↑ 85.2%
Total Assets
$1.3M
↓ 36.2%
EPS (Diluted)
$0.00
N/A
Cash & Equivalents
$85936.00
↑ 540.4%
Shareholders' Equity
$-32180319.00
↓ 104.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ENDV |
| Company Name | ENDONOVO THERAPEUTICS, INC. |
| CIK | 1528172 |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (800) 489-4774 |